Discovery of 1,3-disubstituted pyrazole peripheral cannabinoid receptor partial agonists.
Agonist
CB1
CB2
Cannabinoid
Compound
Peripheral
Journal
Bioorganic & medicinal chemistry letters
ISSN: 1464-3405
Titre abrégé: Bioorg Med Chem Lett
Pays: England
ID NLM: 9107377
Informations de publication
Date de publication:
01 09 2023
01 09 2023
Historique:
received:
17
02
2023
revised:
13
07
2023
accepted:
31
07
2023
pmc-release:
01
09
2024
medline:
21
8
2023
pubmed:
6
8
2023
entrez:
5
8
2023
Statut:
ppublish
Résumé
Partial agonists of peripheral cannabinoid receptors (CBRs) have potential therapeutic applications in several medical conditions. However, (-)-trans-Δ
Identifiants
pubmed: 37543275
pii: S0960-894X(23)00308-6
doi: 10.1016/j.bmcl.2023.129430
pmc: PMC10529378
mid: NIHMS1923600
pii:
doi:
Substances chimiques
Cannabinoid Receptor Agonists
0
Dronabinol
7J8897W37S
Pyrazoles
0
Receptors, Cannabinoid
0
Receptor, Cannabinoid, CB1
0
Receptor, Cannabinoid, CB2
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
129430Subventions
Organisme : NIDA NIH HHS
ID : R01 DA040460
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK124615
Pays : United States
Informations de copyright
Copyright © 2023 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
J Pharmacol Exp Ther. 2004 Aug;310(2):620-32
pubmed: 15140913
J Med Chem. 2021 Jan 14;64(1):385-403
pubmed: 33382613
Biochem Pharmacol. 2018 Nov;157:134-147
pubmed: 30076849
ACS Chem Neurosci. 2015 Sep 16;6(9):1546-59
pubmed: 26134475
Can J Physiol Pharmacol. 2017 Apr;95(4):311-327
pubmed: 28263083
Neuro Endocrinol Lett. 2009;30(2):153-79
pubmed: 19675519
Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):3-26
pubmed: 11259830
Nature. 2016 Dec 22;540(7634):602-606
pubmed: 27851727
Psychopharmacology (Berl). 2014 Feb;231(3):489-500
pubmed: 24005529
Molecules. 2022 Sep 02;27(17):
pubmed: 36080443
Prostaglandins Leukot Essent Fatty Acids. 2002 Feb-Mar;66(2-3):101-21
pubmed: 12052030
ACS Chem Neurosci. 2012 Jan 18;3(1):50-68
pubmed: 22267984
Bioorg Med Chem. 2019 Aug 15;27(16):3632-3649
pubmed: 31301950
Br J Pharmacol. 2016 Feb;173(3):446-58
pubmed: 26398481
J Med Chem. 2018 May 24;61(10):4370-4385
pubmed: 29688015
Pharmacol Rev. 2006 Sep;58(3):389-462
pubmed: 16968947
ACS Chem Neurosci. 2016 Sep 21;7(9):1241-54
pubmed: 27421060
Br J Pharmacol. 2009 Feb;156(3):397-411
pubmed: 19226257
Bioorg Med Chem. 2016 Mar 1;24(5):1063-70
pubmed: 26827137
Cell. 2016 Oct 20;167(3):750-762.e14
pubmed: 27768894
Mol Endocrinol. 2015 Jun;29(6):801-13
pubmed: 25866875
Cell. 2019 Jan 24;176(3):459-467.e13
pubmed: 30639103
Curr Med Chem. 2010;17(14):1468-86
pubmed: 20166921
Biochem Pharmacol. 2018 Nov;157:33-42
pubmed: 30056139
FEBS J. 2013 May;280(9):1918-43
pubmed: 23551849